EBVIA
Ebvia is a privately held biotechnology firm working on innovative outpatient treatment for COVID-19 infections. In a highly deadly animal model, the medication candidate showed survival against SARS-COV-2 infection compared to the control group. In mice infected with the SARS-COV-2 virus, it also reduced lung and brain damage. The candidate is effective against the delta variant and has shown potent efficacy against various influenza strains in animal models.
EBVIA
Social Links:
Industry:
Biotechnology Life Science Outpatient Care Wellness
Founded:
2020-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.ebvia.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Investors List
George Burke
George Burke investment in Pre Seed Round - Ebvia
Official Site Inspections
http://www.ebvia.com Semrush global rank: 6.01 M Semrush visits lastest month: 1.36 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Ebvia"
Ebvia
Ebvia is a privately held biotechnology company developing a novel, outpatient treatment for breakthrough COVID-19 infections. The drug candidate demonstrated 100% survival against …See details»
Ebvia - Crunchbase Company Profile & Funding
Ebvia is a privately held biotechnology firm working on innovative outpatient treatment for COVID-19 infections. In a highly deadly animal model, the medication candidate showed survival …See details»
Contact — Ebvia
Please contact us for more information on our pipeline, press inquiries, careers, and other questions.See details»
Ebvia - LinkedIn
Ebvia Biotechnology Research San Francisco, California 41 followers Advancing multi-target treatments for COVID-19 & pulmonary disorders.See details»
Ebvia, Inc. - San Francisco, USA - bionity.com
Mar 31, 2022 Ebvia is a privately held biotechnology company developing a novel, outpatient treatment for breakthrough COVID-19 infections. The drug candidate demonstrated 100% …See details»
Ebvia - Funding, Financials, Valuation & Investors - Crunchbase
Jan 1, 2022 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 1, 2022: Pre …See details»
Ebvia - Contacts, Employees, Board Members, Advisors & Alumni
Ebvia develops outpatient treatment for COVID-19 and influenza infections.See details»
Privacy Policy — Ebvia
The Site is made available by Ebvia Inc (“Ebvia”, “we”, “us, “our”). Ebvia is the data controller responsible for your personal data. Ebvia Inc is an American company with its registered office …See details»
Ebvia - VentureRadar
Ebvia is a privately held biotechnology company developing a novel, outpatient treatment for breakthrough COVID-19 infections. The drug candidate demonstrated 100% survival against …See details»
Ebvia, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Jun 7, 2024 Explore Ebvia, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Ebvia - Products, Competitors, Financials, Employees, …
Ebvia operates as a biotechnology company focusing on developing treatments. Use the CB Insights Platform to explore Ebvia's full profile. Ebvia - Products, Competitors, Financials, …See details»
Ebvia - Overview, News & Competitors | ZoomInfo.com
Ebvia - Business Information. Business Services · United States · <25 Employees. Ebvia is developing simple-to-use, outpatient therapeutics that provide immediate and as-needed …See details»
Ebvia Overview | SignalHire Company Profile
Ebvia Overview Contact top employees from Ebvia Summary. Advancing multi-target treatments for COVID-19 & pulmonary disorders. Organization Website. ebvia.com . Social Links. Ebvia …See details»
Ebvia - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Ebvia develops outpatient treatment for COVID-19 and influenza infections.See details»
Press Release Distribution and Management - GlobeNewswire
SAN FRANCISCO, March 29, 2022 (GLOBE NEWSWIRE) -- Ebvia, a biotechnology developing simple-to-use therapeutics for the treatment and prevention of COVID-19, today announces …See details»
Partners — Ebvia
© 2021 Ebvia, Inc. Privacy PolicySee details»
Ebvia, Inc. (Ebvia, Inc.) - 药物管线_专利_临床试验_投融营收
了解Ebvia, Inc. (Ebvia, Inc.)公司的药物管线，治疗领域，技术平台，以及它的。See details»
Ebvia - Updates, News, Events, Signals & Triggers - Crunchbase
Organization. Ebvia . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity Section. …See details»
Ebvia Announces Positive Results Published in Nature for …
SAN FRANCISCO, March 29, 2022 (Newswire.com) - Ebvia, a biotechnology developing simple-to-use therapeutics for the treatment and prevention of COVID-19, today announces the …See details»
Ebvia - Crunchbase
Companies like Ebvia include Renovacor, Passage Bio, and Neurexis Therapeutics. Passage Bio Philadelphia , Pennsylvania , United States 92 Contacts 51-100 employeesSee details»